The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
https://www.moleculardxeurope.com/
Eine durchschnittliche Folge dieses Podcasts dauert 8m.
Bisher sind 255 Folge(n) erschienen.
Alle 4 Tage erscheint eine Folge dieses Podcasts.
Gesamtlänge aller Episoden: 1 day 14 hours 15 minutes
World Preclinical Congress 2018 | Next-Generation Screening Platforms: BBB Organoids and Beyond
Dr. Choi-Fong Cho of Harvard Medical School spoke…
PEGS Boston 2018 | Building a Single Donor Phage Antibody Library with NGS Validation
Dr. Andrew Bradbury talks about his latest work u…
Molecular Diagnostics Europe 2018 | The Changing Regulatory Requirements in the EU
Dr. Andreas Stange of TÜV SÜD talks about the pra…
Molecular Diagnostics Europe 2018 | The Role of Epigenetics in Circulating Tumour Cells
Dr. Evi Lianidou outlines what she considers some…
Molecular Diagnostics Europe 2018 | Addressing Challenges in cfDNA Analysis
Dr. Jorg Tost recently spoke to CHI to discuss hi…
Harnessing the power of Big Data and AI for faster, better, and more efficient studies
As more patients become connected, there’s a new …
PEGS Boston 2018 | Discovery of High-Affinity Human PD-1 and LAG-3 Antibodies
Cambridge Healthtech Institute’s Kent Simmons rec…
Molecular Diagnostics Europe 2018 | Cell-Based NIPD: Where Are We Now and Where Are We Going?
Patrizia Paterlini-Brechot spoke to CHI to discus…
Molecular Diagnostics Europe 2018 | The New EU IVD Regulation – What Will It Mean for Your Lab?
Dr. David Barton summarizes the new EU IVD regula…
PEGS Boston 2018 | Challenges and Opportunities in the Next Generation of Bioassays for Biologics
Steven Walfish of the USP recently spoke with CHI…